Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-05-28 @ 1:59 PM
Study NCT ID:
NCT02255656
Status:
COMPLETED
Last Update Posted:
2022-03-28
First Post:
2014-09-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
Sponsor:
Genzyme, a Sanofi Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing Remitting Multiple Sclerosis | View |
Keywords: